Prophecies of the Flood
What to make of the statements of the AI labs?
Related Articles
Financial Toxicity in Cancer Care: Where Are We, and How Did We Get Here? Introduction to a Special Series | JCO Oncology Practice
The first academic article using the term “financial toxicity” was published in 2013, 1 which catalyzed the growth of an emerging field of research and…
Pitfalls and perils from FDA-approved germ-line cancer predisposition tests – PubMed
The FDA approval on September 29, 2023, for “class III de novo” blood tests to assess hereditary cancer risk make widely available tests that may…
Pfizer’s Sasanlimab in Combination with BCG Improves Event-Free Survival in Patients with BCG-Naïve, High-Risk Non-Muscle Invasive Bladder Cancer | Pfizer
C linically meaningful and statistically significant results are the first pivotal Phase 3 data for sasanlimab, a subcutaneously administered PD-1 inhibitor If approved, sasanlimab would…
A call to action: MTHFR polymorphisms should not be a part of inherited thrombophilia testing
Testing for polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene is still a standard part of thrombophilia testing in many laboratories. However, it is clear that…
Axial spondyloarthritis
Axial spondyloarthritis manifests as a chronic inflammatory disease primarily affecting the sacroiliac joints and spine. Although chronic back pain and spinal stiffness are typical initial…
Coroner issues warning about antidepressants after suicide of royal’s husband
Thomas Kingston, son-in-law of Prince and Princess Michael of Kent, had been prescribed SSRIs
The Immune Resistance Signature of Acute Myeloid Leukemia and Current Immunotherapy Strategies
Acute myeloid leukemia (AML) is a complex hematopoietic clonal disorder with limited curative options beyond stem cell transplantation. The success of transplant is intimately linked…
Article of the Week, Suggested by the BPDCN International Registry – OncoDaily
Article of the Week, Suggested by the BPDCN International Registry / Astghik Voskanyan, Blastic Plasmacytoid Dendritic Cell Neoplasm, BPDCN, BPDCN
Synergistic Strategies for KMT2A-Rearranged Leukemias: Beyond Menin Inhibitor
KMT2A-rearranged leukemias are a highly aggressive subset of acute leukemia, characterized by poor prognosis and frequent relapses despite intensive treatment. Menin inhibitors, which target the…
Use www.AirNow.gov
AirNow.gov has been moved to www.AirNow.gov You will be redirected automatically.
